These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16084946)

  • 1. PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration.
    Marsit CJ; Zheng S; Aldape K; Hinds PW; Nelson HH; Wiencke JK; Kelsey KT
    Hum Pathol; 2005 Jul; 36(7):768-76. PubMed ID: 16084946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
    Soria JC; Lee HY; Lee JI; Wang L; Issa JP; Kemp BL; Liu DD; Kurie JM; Mao L; Khuri FR
    Clin Cancer Res; 2002 May; 8(5):1178-84. PubMed ID: 12006535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma.
    Byun DS; Cho K; Ryu BK; Lee MG; Park JI; Chae KS; Kim HJ; Chi SG
    Int J Cancer; 2003 Apr; 104(3):318-27. PubMed ID: 12569555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
    Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
    Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis.
    Hosoya Y; Gemma A; Seike M; Kurimoto F; Uematsu K; Hibino S; Yoshimura A; Shibuya M; Kudoh S
    Lung Cancer; 1999 Aug; 25(2):87-93. PubMed ID: 10470842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.
    Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C
    Genes Chromosomes Cancer; 2002 Sep; 35(1):74-80. PubMed ID: 12203792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of genetic and epigenetic alterations of the PTEN gene in gastric cancer.
    Sato K; Tamura G; Tsuchiya T; Endoh Y; Sakata K; Motoyama T; Usuba O; Kimura W; Terashima M; Nishizuka S; Zou T; Meltzer SJ
    Virchows Arch; 2002 Feb; 440(2):160-165. PubMed ID: 11964046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGR1 predicts PTEN and survival in patients with non-small-cell lung cancer.
    Ferraro B; Bepler G; Sharma S; Cantor A; Haura EB
    J Clin Oncol; 2005 Mar; 23(9):1921-6. PubMed ID: 15774784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Williams NN; Kaiser LR; Croce CM
    Cancer Res; 2003 Jun; 63(12):3352-5. PubMed ID: 12810670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors.
    Di Vizio D; Cito L; Boccia A; Chieffi P; Insabato L; Pettinato G; Motti ML; Schepis F; D'Amico W; Fabiani F; Tavernise B; Venuta S; Fusco A; Viglietto G
    Oncogene; 2005 Mar; 24(11):1882-94. PubMed ID: 15674339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Loss and inactivation of PTEN/MMAC1/TEP1 gene in lung cancer].
    Zhang L; Liu T; Liu H; Gao J; Gu C
    Zhonghua Bing Li Xue Za Zhi; 2000 Apr; 29(2):85-8. PubMed ID: 11866895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers.
    Goel A; Arnold CN; Niedzwiecki D; Carethers JM; Dowell JM; Wasserman L; Compton C; Mayer RJ; Bertagnolli MM; Boland CR
    Cancer Res; 2004 May; 64(9):3014-21. PubMed ID: 15126336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
    Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
    Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged survival after neoadjuvant chemotherapy related with specific molecular alterations in the patients with nonsmall-cell lung carcinoma.
    Stojsic J; Stankovic T; Stojkovic S; Milinkovic V; Dinic J; Milosevic Z; Milovanovic Z; Tanic N; Bankovic J
    Exp Mol Pathol; 2015 Feb; 98(1):27-32. PubMed ID: 25449334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis.
    Velickovic M; Delahunt B; McIver B; Grebe SK
    Mod Pathol; 2002 May; 15(5):479-85. PubMed ID: 12011252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation of the PTEN gene is a common molecular change in breast cancer.
    García JM; Silva J; Peña C; Garcia V; Rodríguez R; Cruz MA; Cantos B; Provencio M; España P; Bonilla F
    Genes Chromosomes Cancer; 2004 Oct; 41(2):117-24. PubMed ID: 15287024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Altered expression of PTEN gene and LOH of its epigenetic microsatellite in gastric carcinoma].
    Li JY; Zheng HC; Yang L; Xu L; Yang XF; Gao H; Zhang YC; Xin Y
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):389-92. PubMed ID: 15355640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.
    Buckingham L; Penfield Faber L; Kim A; Liptay M; Barger C; Basu S; Fidler M; Walters K; Bonomi P; Coon J
    Int J Cancer; 2010 Apr; 126(7):1630-9. PubMed ID: 19795445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN methylation and expression in glioblastomas.
    Baeza N; Weller M; Yonekawa Y; Kleihues P; Ohgaki H
    Acta Neuropathol; 2003 Nov; 106(5):479-85. PubMed ID: 12904991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.